What is Livagen?
Livagen is a synthetic tetrapeptide with the sequence Lys-Glu-Asp-Ala (KEDA). It is one of the short “peptide bioregulators” studied by Vladimir Khavinson’s group at the St. Petersburg Institute of Bioregulation and Gerontology. In that group’s published work it is associated with the liver.
Livagen product specifications
- Compound: Livagen
- Sequence: Lys-Glu-Asp-Ala (KEDA, 4 amino acids)
- Molecular formula: C18H31N5O9
- Molecular weight: about 461.5 g/mol
- Vial size: 20mg
Regulatory status
Livagen is not an approved medicine in the US, UK, EU or Canada. Most published research on it comes from a single research group, so independent confirmation is limited. This product is sold for laboratory research use only.
Related bioregulator peptides
- Ovagen is another Khavinson peptide associated with the liver.
- Pancragen (KEDW), Prostamax (KEDP) and Testagen (KEDG) share its Lys-Glu-Asp start.
Handling and research-use notice
Store and handle this material as stated on the label and certificate of analysis for your batch; see our guide to storing research peptides. This product is sold for laboratory research use only. It is not a medicine or supplement and is not for human or veterinary use.
